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Background: Aboriginal and Torres Strait Islander women experience higher rates of heart disease and type 2
diabetes than non-Indigenous Australian women. Increasing physical activity, improving diets and losing weight
have been shown to reduce cardio metabolic risk. The primary aim was to evaluate the effectiveness of a 12-week
structured exercise and nutrition program in a cohort of urban Indigenous Australian women on waist
circumference, weight and biomedical markers of metabolic functioning from baseline (T1) to program completion
(T2). The secondary aim assessed whether these outcomes were maintained at 3-month follow-up.
Methods: One hundred Aboriginal and/or Torres Strait Islander women aged 18–64 years living in the Adelaide
metropolitan area were recruited. The program included two 60-minute group cardiovascular and resistance
training classes per week, and four nutrition education workshops. Participants were randomly assigned to an
‘active’ group or ‘waitlisted’ control group. Body weight, height, waist and hip circumference, blood pressure,
fasting glucose, fasting insulin, glycated haemoglobin (HbA1C), lipid profile and C-reactive protein (CRP) were
assessed at baseline (T1), immediately after the program (T2) and three months post program (T3).
Results: The active group showed modest reductions in weight and body mass index (BMI). Compared to the
waitlisted group, the active group had a statistically significantly change in weight and BMI from baseline
assessments; at T2, -1.65 kg and -0.66 kg/m2 and at T3, -2.50 kg and -1.03 kg/m2, respectively. Systolic and diastolic
blood pressure also had a statistically significant difference from baseline in the active group compared to the
waitlisted group at T2, -1.24 mmHg and -2.46 mmHg and at T3, -4.09 mmHg and -2.17 mmHg, respectively. The
findings were independent of the baseline measure of the outcome variable, age, households with children and
employment status. Changes in waist circumference and other clinical measures were not significant at T2 or T3.
The primary outcome measure, waist circumference, proved problematic to assess reliably. Missing data and
participants lost to follow-up were significant.
Conclusions: This 12-week exercise program demonstrated modest reductions in weight, BMI and blood pressure
at T2, which improved further at 3-month follow-up (T3). Positive intervention effects were observed despite low
attendance at exercise classes. Structured exercise programs implemented in community settings require attention
to understanding the barriers to participation for this high risk group.
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The Australian National Aboriginal and Torres Strait Is-
lander Health Survey (NATSIHS) and the National
Health Survey (NHS) were conducted between 2004 and
2005. The data were analysed and reported in the Abori-
ginal and Torres Strait Islander Health Performance
Framework 2010 [1]. The rates of obesity and type 2
diabetes mellitus (T2DM) reported for Australian Indi-
genous women were much higher compared to non-
Indigenous women. Rates of obesity based on body mass
index (BMI) derived from self-reported height and
weight were 36.8% for Indigenous women, and signifi-
cantly higher than non-Indigenous women (16.7%) [1].
Self-reported T2DM was 11% for Indigenous women
compared to 3% of non-Indigenous women in non-
remote areas [1]. The NATSIHS & NHS surveys also
reported that 53% of Indigenous women are sedentary,
which is significantly more than the 34% of non-
Indigenous women [1]. Young Indigenous women, aged
15–34 years, significantly increased their weight and
waist circumference during a 7-year longitudinal study
in Far North Queensland. Aboriginal women gained an
average of 1.5 kg (kg) in weight and 1.6 cm (cm) around
their waist per year while the Torres Strait Islander
women gained an average of 1.2 kg and increased their
waist by 1.2 cm each year [2]. The life expectancy gap
between Indigenous and non-Indigenous women is cur-
rently estimated at ten years [3].
Research consistently supports that regular physical
activity is effective in the primary and secondary preven-
tion of many chronic diseases, including diabetes [4].
Programs incorporating physical activity and nutrition
education have been shown to reduce body weight [5],
blood pressure [6,7] the incidence of T2DM in 'at risk'
participants [8] and improve glycemic control and
reduce diabetes-related complications in diagnosed
patients [9,10].
Implementing and evaluating well designed physical
activity and nutrition education studies targeting Indi-
genous populations is difficult and consequently the evi-
dence limited [9,11]. A 4-month structured physical
activity program for Maori men and women reported a
decrease in weight and body mass index (BMI) and an
improvement in systolic and diastolic blood pressure
[12]. However, the study did not include a control group
and consisted of only 30 participants. The Community
Health Assessment and Promotion Project (CHAPP)
was a 10-week nutrition and physical activity program
with 72 ‘black’ female participants aged 18 – 59 [13].
CHAPP also reported favourable results for weight loss
and blood pressure but utilised a pre-post design with
no control group [13].
The Aboriginal and Torres Strait Islander Women’s
fitness program was informed by a pilot project, the‘Thursday Island Women’s Fitness Challenge’, which was
undertaken in a remote setting. The pilot study was an
8-week program that included structured group circuit
and aqua aerobics classes conducted twice a week. The
study did not include a control group. Participants
attending the post program assessment (n=10) lost
4.93 cm from their waist and 0.03 kg in weight. Blood
pressure was not assessed [14].
This study aimed to implement and evaluate the ef-
fectiveness of the 12-week structured exercise and nutri-
tion education program in a cohort of urban Indigenous
Australian women on waist circumference, weight and
biomedical markers of metabolic functioning. We
hypothesised that the active group who participated in
the intervention would achieve a significant reduction in
waist circumference and improved metabolic functioning
compared to the waitlisted group immediately following




Aboriginal and Torres Strait Islander women from the
Adelaide metropolitan area were invited to participate in
the program. Women were eligible if they identified as
being of Aboriginal and/or Torres Strait Islander des-
cent, aged between 18 and 64 years, and had a waist cir-
cumference greater than 80 cm. Participants were
excluded if they were pregnant or were deemed physic-
ally unable to participate by their doctor. The recruit-
ment process is described in detail elsewhere [15].
Participants were recruited in three intakes over ap-
proximately 13 months starting in January 2010. Figure 1
shows the pathway of participants from registration to
group assignment and baseline assessment. A total of
119 women registered to participate in the program.
One participant was ineligible due to pregnancy however
she re-registered for the second intake after the birth of
her child. Each intake was randomised to form two
groups of even size; an ‘active’ and ‘waitlisted’ group.
Each group was assigned a letter, with A, C and E being
the ‘active’ groups and B, D and F being the ‘waitlisted’
groups. Attempts were made to assess participant’s base-
line waist circumference before randomly assigning them
to the ‘active’ or ‘waitlisted’ groups. Nine participants did
not meet the waist circumference eligibility criteria,
seven of whom were excluded before randomisation and
an additional two participants who had been assigned to
group F. Nine participants failed to attend their baseline
anthropometric assessment and were excluded from
analysis.
Some participants were lost to follow-up (LTF) and/or
chose not to participate in all assessments at all assess-
ment time points. Participants were considered ‘lost to
Figure 1 Participant flow chart. Participant numbers from registration through to the allocation of groups and their participation in the three
assessments time points (T1, T2 and T3).
Canuto et al. BMC Public Health 2012, 12:933 Page 3 of 11
http://www.biomedcentral.com/1471-2458/12/933follow-up’ if they did not attend any part of the T3
assessments or subsequent assessments. The results
reported here include the assessment at baseline (T1),
immediately post program (T2) and 3 months post pro-
gram (T3). These three assessments are approximately
three months apart.
All eligible participants attended the baseline an-
thropometric assessment however fasting blood tests
were not all completed and missing data increased over
subsequent assessment time points. The completionrates of the anthropometric and pathology assessments
are summarised in Table 1.
Program
The Aboriginal and Torres Strait Islander Women’s Fit-
ness Program is a structured 12-week group program.
There are four key components of the intervention; the
group exercise classes, incidental activity and walking,
nutrition workshops and positive reinforcement and
encouragement. During the 12-week intervention
Table 1 Number and percentage of participants who
attended anthropometric and pathology assessments at
T1, T2, and T3
Anthropometrics N (%) Pathology N (%)
Waitlisted Active Waitlisted Active
T1 49 (100) 51 (100) 29 (59) 44 (86)
T2 35 (71) 36 (71) 26 (53) 23 (45)
T3 29 (59) 27 (53) 23 (47) 49 (49)
Percentages are calculated on the total number of participants at T1.
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cise sessions per week facilitated by qualified female
fitness instructors. The exercise sessions were imple-
mented as outlined in the facilitator manual. Each exer-
cise session incorporated both aerobic and resistance
training for 60 minutes. Participants were also encour-
aged to aim for 10,000 steps per day. Steps were assessed
using Yamax SW200 pedometers (Yamax Corp., Tokyo)
and were self-recorded in an exercise diary provided.
During the 12-week program four 1-hour nutrition work-
shops were delivered by a female dietician. Nutrition
topics included food label reading, recipe modification
and a cooking demonstration. Fortnightly newsletters
were distributed to participants. Each newsletter
included a healthy recipe, nutrition and exercise tips and
acknowledged the participants from their group logging
the most steps since the previous newsletter.
Waitlisted women received the same pedometer and
exercise diary as the active group. To keep the waitlisted
group engaged, they also received monthly newsletters
with a recipe and tips on physical activity and healthy
eating and were invited to attend four 1-hour workshops
facilitated by a dietician. Waitlisted participants were
offered the structured physical activity program approxi-
mately 12 months after their baseline assessment. The
program is described in more detail elsewhere [15].Outcome measures
Participant’s demographic data was collected via a ques-
tionnaire completed during the baseline assessment
period (T1). Participants reported employment status,
household income and highest educational attainment.
Some categories were collapsed due to low numbers. The
number of children and number of adults in the house-
hold were separate, open ended questions. For regression
analysis dichotomous categories for ‘kids in the household’
(no children and at least one child) and employed (un-
employed and employed) were created. Participants were
asked to identify their ethnicity (Aboriginal and/or Torres
Strait Islander). All participants identified as Aboriginal
except for two women who identified as being both of
Aboriginal and Torres Strait Islander descent. Analyses
were not adjusted for ethnicity.Height, weight, waist and hip circumference, blood
pressure and fasting venous blood samples were col-
lected from participants at baseline (T1), immediately
after the program (T2) and three months after the com-
pletion of the program (T3). The average time period
between T1 and T2 was 112 days (95% confidence inter-
val (CI) 109–115 days). The average time period between
T1 and T3 was 189 days (95% CI, 187–192).
Anthropometric assessments were conducted using
the protocols developed by the International Society for
the Advancement of Kinanthropometry (ISAK) [16]. An
ISAK accredited assessor measured participant’s height,
weight, waist and hip circumference which were all mea-
sured twice and were averaged. If the two measurements
were not within the acceptable error range (3%), a third
assessment was taken and the outlier dismissed. Blood
pressure was taken three times at each assessment using
a digital Ormon T8 (JA Davey Pty Ltd; Melbourne, Vic,
Australia). An average systolic and diastolic blood pres-
sure was calculated using all available measurements.
These assessments are explained in detail in the study
protocol [15].
The pathology company, Healthscope Inc., collected
and analysed the fasting blood samples. Participants
could get their blood pathology test by attending one
of the 51 Adelaide pathology clinics in their own time,
by home visit or during the anthropometric assessment
when a phlebotomist was present. Fasting blood glucose
was analysed using the Hexokinase assay with Siemens
Advia 2400 (Siemens Healthcare Diagnostics Inc.,
New York, USA). Fasting serum insulin, total choles-
terol, high-density lipoprotein (HDL) and triglyceride
concentrations were analysed using Chemiluminescent
Immunoassay with Siemens Advia 2400. Glycated
haemoglobin (HbA1C) was analysed using the Immu-
noturbidimetry assay with Roche Integra 800 (Roche
Diagnostics Ltd. West Sussex, UK). C-reactive protein
(CRP) was analysed using the Immunoturbidimetry
assay with Siemens Advia 2400. For analysis, CRP
values greater than 100 mg/L were replaced with miss-
ing values as this indicates a bacterial infection rather
than a chronic underlying inflammatory state. Low-
density lipoprotein (LDL) was calculated by Health-
scope Inc. Homeostatic model assessment for insulin
resistance (HOMA-IR) is calculated using the formula:
HOMA-IR = (fasting glucose [mmol/L] × fasting insulin
[μU/mL])/22.5.
Diabetes status was determined by self-reported diagno-
sis of type 2 diabetes or if participants reported taking
T2DM medications. Additionally participants were classi-
fied as having T2DM if their fasting glucose was greater
than 7.0 mmol/L at their baseline pathology assessment,
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nostic criteria [17].
Participation in the exercise classes and nutrition
workshops was recorded by project staff. Fidelity was
assessed at each exercise class by a project staff member
(not by the fitness instructor). The fidelity tool assessed
the completion of and any modifications of the program
for each major component of the class.
Ethics
This project received ethics approval from the Human
Research Ethic Committees of the University of South
Australia (reference number P006/09) and the Aborigi-
nal Health Council of South Australia (reference number
04-09-298).
Community consultation
The project has been given advice and guidance from
their collaborating partners, Nunkuwarrin Yunti of South
Australia Inc and the Aboriginal Sobriety Group Inc. in
Adelaide, and a specially formed advisory committee of
local Aboriginal and Torres Strait Islander women.Table 2 Demographics at baseline by group
Wai
No.
Employment unemployed 9 (1
Part time 11 (
Full time 28 (
Unanswered 1 (2
Education (highest attained) < year 12 13 (



















Questions that a participant left blank or the response could not be interpreted hav
Abbreviations: TAFE = “Technical And Further Education” or vocational studies.Statistical analysis
Data analysis was performed in Stata11 [18]. The demo-
graphic characteristics are summarised in Table 2 and
clinical outcomes, including diabetes status, displayed in
Table 3. These tables illustrate the similarities and differ-
ences between the two randomly assigned groups. The
descriptive analyses of demographics and baseline
assessments were repeated by group and follow-up sta-
tus in Tables 4 and 5 to explore the differences between
participants lost to follow and those with T3 data for
both groups. The effect of program participation on all
anthropometric, blood pressure and pathology results
was conducted using linear regression (Tables 6 and 7).
Linear regression was performed on the change of each
variable between time points, firstly from baseline (T1)
to immediately post program (T2) (Table 6), then be-
tween baseline (T1) and 3-month post program (T3)
(Table 7). This was done with and without adjusting for
potential confounders. Tables 6 and 7 show regression
analysis with four models; model 1 is crude without
adjustments, model 2 adjusts for age and baseline meas-
ure of the outcome variable, model 3 adjustments fortlisted group N=49 Active group N=51
(%) 95% CI No. (%) 95% CI
8) 7.5-30.0 16 (31) 18.8-45.2
22) 10.7-35.1 9 (18) 7.1-28.9
57) 44.1-72.6 25 (49) 35.8-64.2
) — 1 (2) —
35) 19.3-51.0 11 (25) 11.9-38.1
1) 0.5-21.1 7 (16) 4.8-27.0
6) 8.0-35.3 17 (33) 23.9-53.4
24) 16.9-48.0 9 (18) 8.2-32.7
24) — 7 (14) —
29) 21.1-52.9 15 (29) 19.2-47.5
27) 18.7-49.7 13 (25) 15.3-42.5
22) 14.1-43.8 17 (33) 23.2-52.3
22) — 6 (12) —
31) 23.5-55.5 13 (25) 16.1-44.3
8) 9.8-37.6 20 (39) 31.2-61.8
8) 9.8-37.6 4 (8) 0.4-18.2
0) 2.1-24.2 6 (12) 3.3-24.6
22) — 8 (16) —
22) 14.1-43.8 23 (45) 38.2-68.8
8) 7.7-34.4 5 (10) 1.8-21.5
8) 5.7-31.1 6 (12) 3.3-24.6
4) 7.7-34.4 6 (12) 3.3-24.6
) 0.5-20.6 3 (6) −0.8-14.8
8) — 8 (16) —
e been coded as “unanswered”.
Table 3 Baseline mean anthropometric and blood measurements by group
Waitlisted N=49 Active N=51
Mean 95% CI Mean 95% CI
Age Age (years) 40.7 37.7-43.6 39.8 36.7-43.1
Anthropometrics Height (m) 1.62 1.61-1.64 1.61 1.60-1.62
Weight (kg) 88.8 82.8-94.8 94.0 88.1-99.9
BMI (kg/m2) 33.5 31.5-35.6 36.1 34.0-38.2
Waist (cm) 101.5 97.0-106.0 104.2 100.0-108.3
Hip (cm) 117.0 112.3-121.7 120.6 115.9-125.2
Waist to Hip Ratio 0.87 0.85-0.89 0.87 0.85-0.88
Blood Pressure Systolic BP (mmHg) 129.5 124.1-135.0 129.4 125.4-133.4
Diastolic BP (mmHg) 87.5 83.9-91.1 88.3 85.3-91.3
Pathology Glucose (mmol/L) 6.4 5.1-7.7 5.6 4.9-6.3
Insulin (mU/L) 17.4 14.1-20.7 17.5 14.7-20.2
HbA1c (%) 6.5 6.0-7.1 6.1 5.7-6.4
Cholesterol (mmol/L) 4.6 4.3-5.0 4.9 4.6-5.2
Triglycerides (mmol/L) 1.5 1.1-1.8 1.5 1.3-1.7
LDL (mmol/L) 2.8 2.4-3.0 3.0 2.8-3.2
HDL (mmol/L) 1.2 1.1-1.3 1.2 1.1-1.3
LDL:HDL 2.4* 2.1-2.7 2.6 2.3-2.9
Cholesterol:HDL 4.1 3.6-4.5 4.2 3.8-4.5
CRP (mg/L) 7.2 4.4-10.0 7.5# 5.6-9.4
Calculated HOMA-IR HOMA-IR 5.3 3.4-7.2 4.3 3.6-5.1
The observations for blood pressure were reduced due to missing data; waitlisted participants n=45, active participants n=49. The observations for pathology
results were reduced due to missing data; waitlisted participants n=29, active participants n=44.
* Observation reduced by one. LDL value missing – invalid as triglyceride concentration was > 4.5 mmol/L.
# Observation reduced by one. CRP was > 100 mg/L indicating bacterial infection.
Abbreviations: CI = confidence intervals; BMI = body mass index; Waist = waist circumference; Hip = hip circumference; HbA1C = glycated haemoglobin; LDL =
low-density lipoprotein; HDL = high-density lipoprotein; CRP = C-reactive protein; HOMA-IR = Homeostatic model assessment for insulin resistance.
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demographic confounders, and model 4 builds on model
3 with T2DM status included. The demographic con-
founders are employment status and kids in the house-
hold which were both collapsed into dichotomous
variables and any missing data were dropped. These
demographic confounders were chosen because of the
uneven distribution of the characteristic by group at




Tables 2 and 3 summarise participant characteristics at
baseline, comparing the active and waitlisted groups.
There were no statistical differences between the two
groups at T1.
Tables 4 and 5 compare the baseline characteristics of
participants by group and T3 follow-up status. There
were no statistical differences in any of the baseline
demographics or diabetes status between the partici-
pants lost to follow-up (LTF) and those who attended
their T3 assessment from either group (Table 4). Therewere, however, statistical differences between the active
participants LTF and those assessed at T3 in baseline
age, cholesterol and CRP concentration. The women
LTF from the active group were on average younger,
with lower total cholesterol, triglyceride concentration,
and LDL cholesterol and higher CRP concentrations
(Table 5). Additionally, there was a statistical difference
between those LTF and those assessed from the wait-
listed group, those LTF on average weighed less, had a
lower BMI, and smaller waist and hip circumferences
(Table 5).
Program fidelity and attendance
The 12-week program was implemented as intended for
all three groups (Groups A, C and E). Key activities for
each class were implemented as outlined in the facilita-
tor’s manual. Class duration averaged 59 min. Session at-
tendance by the active group was low. Participants were
encouraged to attend two classes per week for twelve
weeks. The average number of classes attended was 9.5
(95% CI, 7.4 - 11.6) of which 7 participants did not at-
tend a single exercise class; 6 of these participants with-
drew from the program and the other participant
Table 4 Participant demographics and T2DM status at baseline by group and T3 follow-up status









Employment unemployed 20.0 (5–35) 15.8 (0–34) 17.2 (3–32) 50.0 (27–73)
Part time 26.7 (10–43) 15.8 (0–34) 20.7 (5–36) 13.6 (0–29)
Full time 53.3 (34–72) 63.2 (39–87) 58.6 (40–78) 36.4 (15–58)
Unanswered — 5.3 (0–16) 3.4 (0–11) —
Education < year 12 20.0 (5–35) 36.8 (13–61) 24.1 (8–41) 18.2 (1–36)
Year 12 10.0 (0–21) 5.3 (0–16) 10.3 (0–22) 18.2 (1–36)
TAFE 26.6 (10–43) — 27.6 (10–45) 40.9 (19–63)
University 23.3 (7–39) 26.3 (5–48) 24.1 (8–41) 9.1 (0–2)
Unanswered 20.0 (5–35) 31.6 (9–55) 13.8 (0–27) 13.6 (0–29)
Income <$40,000 16.0 (1–31) 35.7 (7–64) 8.3 (0–20) 12.5 (0–31)
$40,000-$60,000 32.0 (12–52) 28.6 (2–56) 29.2 (10–49) 37.5 (11–64)
$60,000 28.0 (9–47) — 50.0 (28–72) 31.2 (6–57)
Unanswered 24.0 (6–42) 35.7 (7–64) 12.5 (0–27) 19.0 (0–40)
No. of adults in the
household
1 30.0 (13–47) 32 (9–55) 27.6 (10–45) 22.7 (4–42)
2 16.7 (3–31) 21.1 (9–41) 41.4 (22–60) 36.4 (15–58)
3 26.7 (10–43) 5.3 (0–16) 13.8 (0–27) 18.0 (1–36)
≥4 6.7 (0–16) 16.0 (0–34) 6.9 (0–17) —
Unanswered 20.0 (5–35) 26.3 (5–48) 10.3 (0–22) 22.7 (4–42)
No. of children in the
household
0 20.0 (5–35) 26.3 (5–48) 37.9 (19–57) 54.5 (32–77)
1 16.7 (3–31) 21.0 (1–41) 17.2 (3–32) —
2 20.0 (5–35) 15.8 (0–34) 17.2 (3–32) 4.5 (0–14)
3 16.7 (3–31) 10.5 (0–26) 13.8 (0–27) 9.1 (0–22)
≥4 6.7 (0–16) 10.5 (0–26) 3.4 (0–11) 9.1 (0–22)
Unanswered 20.0 (5–35) 15.8 (0–34) 10.3 (0–22) 22.7 (4–42)
Diabetes* Diabetic 26.7 (10–43) 21.1 (2–40) 17.2 (3–32) 13.6 (1–29)
non-diabetes 73.3 (57–89) 78.9 (60–98) 82.8 (68–97) 86.4 (71–101)
Questions that a participant left blank or the response could not be
interpreted have been coded as “unanswered”.
* Diabetes was defined by self-reported diagnosis, self-reported prescription of T2DM medications or fasting glucose > 7.0 mmol/L at T1, in accordance with the
World Health Organization diagnostic criteria [17].
Abbreviations: TAFE = “Technical And Further Education” or vocational studies; LTF = lost to follow-up.
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workshops also experienced low attendance. Of the four
nutrition education workshops, the average number
attended was 1 workshop, with 24 of the 51 active parti-
cipants not attending a single nutrition workshop. The
waitlisted participants also had low attendance at their
workshops.
Multivariable results
Regression analysis was conducted to determine the as-
sociation between group (i.e. active or waitlisted) and
the mean change in anthropometric and clinical assess-
ments over time. Table 6 shows the difference from
baseline to immediately post program (i.e. T1 - T2) and
Table 7 shows the change between baseline and threemonths post program (i.e. T1 - T3). A negative coeffi-
cient indicated that the active group had a reduction
in the outcome variable compared with the waitlisted
group.
Changes from baseline to immediate post
program (T1-T2)
After adjusting for the baseline weight, age, children in
the household, employment status and T2DM, there was
a modest, yet statistically significant difference in weight
within the active group compared to the waitlisted group
from baseline to T2, -1.65 kg (95% CI, -3.27 - -0.03)
(Table 6). Similarly, there was a statistically significant
difference in BMI of the active group compared to the
waitlisted group from baseline to T2, -0.66 kg/m2 (95%
Table 5 Baseline age and clinical markers by group and T3 follow-up status
Waitlisted group N=49 Active group N=51
Followed-up
N=30 Mean (95% CI)
LTF at T3
N=19 Mean (95% CI)
Followed-up
N=29 Mean (95% CI)
LTF at T3
N=22 Mean (95% CI)
Age (year) 41.7 (38.1-45.3) 39.1 (33.6-44.5) 43.5 (39.6-47.4) 35.1 (30.2-40.1)
Weight (kg) 94.8 (86.3-103.4) 79.2 (73.3-85.0) 92.6 (84.5-100.6) 95.9 (86.5-105.2)
BMI (kg/m2) 35.5 (32.5-38.5) 30.4 (28.4-32.5) 35.5 (32.5-38.5) 36.8 (33.8-39.9)
WC (cm) 106.4 (100.0-112.8) 93.8 (89.6-98.0) 103.2 (97.9-108.6) 105.4 (98.5-112.4)
Hip (cm) 121.7 (115.1-128.4) 109.4 (104.5-114.3) 120.0 (113.3-126.7) 121.3 (114.6-128.1)
Systolic BP (mmHg) 129.5 (121.9-137.0) 129.7 (121.3-138.1) 129.1 (123.9-134.3) 129.9 (123.0-136.8)
Diastolic BP (mmHg) 88.1 (83.2-92.9) 86.6 (80.7-82.4) 87.2 (83.6-90.8) 89.9 (84.3-95.4)
Glucose (mmol/L) 6.6 (5.0-8.2) 5.6 (3.5-7.7) 5.8 (4.7-6.8) 5.2 (4.5-5.9)
Insulin (mU/L) 16.1 (12.9-19.3) 22.3 (10.1-34.5) 17.2 (13.7-20.7) 18.6* (13.2-24.1)
HbA1c (%) 6.6 (5.9-7.2) 6.4 (5.5-7.3) 6.2 (5.7-6.6) 6.0* (5.4-6.6)
Cholesterol (mmol/L) 4.6 (4.3-5.0) 4.6 (3.7-5.4) 5.2 (4.9-5.6) 4.2 (3.9-4.6)
Triglycerides (mmol/L) 1.6 (1.1-2.0) 1.1 (0.8-1.5) 1.7 (1.4-2.0) 1.2 (0.8-1.5)
LDL (mmol/L) 2.8* (2.4-3.1) 2.7 (1.8-3.6) 3.3 (3.0-3.6) 2.5 (2.2-2.8)
HDL (mmol/L) 1.1 (1.0-1.2) 1.3 (1.0-1.6) 1.2 (1.1-1.3) 1.2 (1.0-1.3)
CRP (mg/L) 7.6 (4.2-11.0) 5.6 (1.1-10.2) 6.2 (3.8-8.6) 10.2# (7.5-12.9)
The observations for blood pressure were reduced due to missing data; waitlisted participants followed up n=27, LTF n=18, active participants LTF n=20.
The observations for pathology results were reduced due to missing data; waitlisted participants followed up n=23, LTF n=6, active participants LTF n=15.
* Observation reduced by one. LDL value missing – invalid as triglyceride concentration was > 4.5 mmol/L.
# Observation reduced by one. CRP was > 100 mg/L indicating bacterial infection.
Abbreviations: CI = confidence intervals; BMI = body mass index; Waist = waist circumference; Hip = hip circumference; HbA1C = glycated haemoglobin; LDL =
low-density lipoprotein; HDL = high-density lipoprotein; CRP = C-reactive protein.
Table 6 Regression of mean change in outcome variables from baseline to immediate post program (T1-T2)
N Model 1 p value Model 2 p value Model 3 p value Model 4 p value
β coeff 95% CI β coeff 95% CI β coeff 95% CI β coeff 95% CI
Weight (kg) 71 −1.85 −3.43- -0.27 0.022 −1.84 −3.44- -0.24 0.025 −1.56 −3.15-0.04 0.055 −1.65 −3.27- -0.03 0.046
BMI (kg/m2) 71 −0.76 −1.35- -0.16 0.013 −0.76 −1.36- -0.16 0.015 −0.64 −1.24- -0.04 0.036 −0.66 −1.27- -0.05 0.035
Waist (cm) 71 −1.36 −3.26-0.54 0.158 −1.45 −3.37-0.46 0.134 −1.39 −3.36-0.59 0.166 −1.50 −3.50-0.51 0.140
Hip (cm) 71 −0.71 −2.52-1.09 0.434 −0.79 −2.53-0.95 0.371 −0.83 −2.60-0.94 0.353 −0.84 −2.65-0.97 0.357
Systolic BP
(mmHg)
66 −0.19 −6.55-6.17 0.952 −0.99 −6.57-4.58 0.723 −1.75 −7.53-4.02 0.546 −1.24 −7.09-4.62 0.674
Diastolic BP
(mmHg)
66 −1.64 −6.71-3.42 0.519 −1.95 −6.33-2.43 0.377 −2.15 −6.69-2.38 0.347 −2.46 −7.09-2.17 0.293
Insulin (mU/L) 44 −1.91 −7.18-3.36 0.468 −1.65 −7.07-3.76 0.540 −1.26 −6.72-4.20 0.643 0.48 −4.80-5.77 0.854
Glucose
(mmol/L)
44 0.33 −1.03-1.69 0.628 −0.54 −1.57-0.50 0.300 −0.64 −1.67-0.39 0.217 −0.47 −1.42-0.47 0.316
HbA1c (%) 44 −0.14 −0.37-0.09 0.221 −0.04 −0.25-0.18 0.723 −0.05 −0.27-0.17 0.646 −0.04 −0.25-0.18 0.741
Cholesterol
(mmol/L)
44 −0.10 −0.48-0.29 0.619 0.03 −0.36-0.42 0.877 0.032 −0.38-0.44 0.878 0.00 −0.42-0.42 0.994
Triglycerides
(mmol/L)
44 −0.03 −0.30-0.24 0.847 −0.03 −0.28-0.22 0.787 −0.03 −0.29-0.23 0.812 0.02 −0.24-0.28 0.879
LDL (mmol/L) 43 0.00 −0.31-0.31 0.998 0.08 −0.24-0.39 0.617 −0.03 −0.29-0.23 0.812 0.05 −0.27-0.37 0.755
HDL (mmol/L) 44 −0.06 −0.15-0.03 0.194 −0.03 −0.11-0.05 0.453 −0.03 −0.11-0.06 0.511 −0.04 −0.12-0.05 0.410
CRP (mg/L) 44 −0.80 −3.73-2.14 0.587 −0.55 −3.48-2.38 0.705 −0.69 −3.62-2.23 0.635 −0.57 −3.63-2.50 0.710
Model 1 is crude and unadjusted. Model 2 is adjusted for age at baseline and the baseline assessment of the respective outcome measure. Model 3 is adjusted
for the confounders in Model 2 plus kids in the household and employment status. Model 4 adjusts for all potential confounders in model 3 plus T2DM status.
Abbreviations: CI = confidence intervals; BMI = body mass index; Waist = waist circumference; Hip = hip circumference; HbA1C = glycated haemoglobin;
LDL = low-density lipoprotein; HDL = high-density lipoprotein; CRP = C-reactive protein.
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Table 7 Regression of mean change in outcome variables from baseline to 3 months post program (T1-T3)
N Model 1 p value Model 2 p value Model 3 p value Model 4 p value
β coeff 95% CI β coeff 95% CI β coeff 95% CI β coeff 95% CI
Weight (kg) 56 −2.17 −4.09- -0.25 0.028 −2.13 −4.11- -0.15 0.036 −2.20 −4.16-0.24 0.029 −2.50 −4.46- -0.54 0.013
BMI (kg/m2) 56 −0.95 −1.69- -0.21 0.013 −0.92 −1.68- -0.16 0.019 −0.91 −1.68- -0.15 0.020 −1.03 −1.79- -0.27 0.009
Waist (cm) 56 −1.81 −4.31-0.69 0.153 −1.60 −4.19-0.99 0.220 −1.49 −4.12-1.14 0.261 −1.50 −4.20-1.19 0.268
Hip (cm) 56 −1.16 −3.73-1.41 0.370 −1.44 −4.00-1.13 0.265 −1.52 −3.98-0.95 0.223 −1.97 −4.39-0.45 0.108
Systolic BP
(mmHg)
53 −3.26 −9.15-2.63 0.271 −3.38 −9.19-2.42 0.247 −4.00 −9.74-1.74 0.168 −4.09 −10.01-1.83 0.171
Diastolic BP
(mmHg)
53 −1.43 −5.21-2.34 0.449 −1.94 −5.75-1.88 0.312 −2.13 −5.99-1.73 0.273 −2.17 −6.15-1.81 0.279
Insulin (mU/L) 44 1.22 −2.92-5.37 0.554 1.46 −2.52-5.44 0.462 1.34 −2.76-5.43 0.513 1.64 −2.54-5.82 0.432
Glucose
(mmol/L)
45 −0.47 −1.11-0.17 0.143 −0.54 −1.18-0.10 0.095 −0.55 −1.20-0.11 0.101 −0.46 −1.08-0.17 0.149
HbA1c (%) 44 −0.29 −0.58-0.01 0.057 −0.20 −0.47-0.06 0.124 −0.22 −0.49-0.04 0.095 −0.23 −0.50-0.04 0.092
Cholesterol
(mmol/L)
45 −0.22 −0.61-0.17 0.261 0.01 −0.37-0.38 0.969 0.03 −0.34-0.41 0.865 −0.03 −0.40-0.33 0.859
Triglycerides
(mmol/L)
45 −0.26 −0.63-0.12 0.174 −0.22 −0.58-0.14 0.225 −0.22 −0.57-0.14 0.221 −0.26 −0.63-0.10 0.151
LDL (mmol/L) 44 −0.10 −0.45-0.24 0.544 0.08 −0.25-0.40 0.659 0.08 −0.25-0.41 0.635 0.07 −0.26-0.39 0.675
HDL (mmol/L) 45 −0.01 −0.11-0.08 0.760 0.00 −0.09-0.09 0.978 0.00 −0.10-0.09 0.946 −0.01 −0.11-0.08 0.801
CRP (mg/L) 44 −1.15 −4.72-2.41 0.517 −0.79 −4.36-2.77 0.655 −1.02 −4.52-2.49 0.560 −1.05 −4.66-2.56 0.559
Model 1 is crude and unadjusted. Model 2 is adjusted for age at baseline and the baseline assessment of the respective outcome measure. Model 3 is adjusted
for the confounders in Model 2 plus kids in the household and employment status. Model 4 adjusts for all potential confounders in model 3 plus T2DM status.
Abbreviations: CI = confidence intervals; BMI = body mass index; Waist = waist circumference; Hip = hip circumference; HbA1C = glycated haemoglobin;
LDL = low-density lipoprotein; HDL = high-density lipoprotein; CRP = C-reactive protein.
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models (see Table 6) indicating that the potential con-
founders had little effect on the results. The active group
had decreases in waist and hip circumference, -1.50 cm
and -0.84 cm respectively compared to the waitlisted
group however this is within the 2% measurement error
margin and was not statistically significant. The active
group also had decreases in systolic and diastolic blood
pressure relative to the waitlisted group although blood
pressure was measured with low precision and these
changes were not statistically significant however, it may
be clinically significant (-1.24 mmHg and -2.46 mmHg).
CRP concentrations also changed from baseline to T2
for the active group relative to the waitlisted participants
(-0.57 mg/L), however, this was not statistically signifi-
cant. There is no difference between groups for fasting
glucose, fasting insulin, HbA1c, total cholesterol, trigly-
ceride concentrations, LDL cholesterol and HDL
cholesterol.
Changes from baseline to three months post
program (T1-T3)
After adjusting for baseline weight, age, children in the
household, employment status and T2DM the active
group had a statistically significant reduction in weight
compared to the waitlisted group from baseline to T3
(Table 7). The change in weight from baseline to T3 ofthe active group relative to the waitlisted group was
-2.50 kg (95% CI, -4.46 - -0.54). Similarly there was a sta-
tistically significant difference between baseline BMI and
BMI at T3 between the active and waitlisted groups;
-1.03 kg/m2 (95% CI, -1.79 - -0.27). The relative differ-
ence in the change of waist and hip circumference be-
tween baseline and T3 of the two groups was not
statistically significant but was -1.50 cm and -1.97 cm re-
spectively. Systolic and diastolic blood pressure was also
improved in the active group relative to the waitlisted
group from baseline to T3 but did not reach statistical
significance; -4.09 mmHg (95% CI, -10.01 - 1.83) and
-2.17 mmHg (95% CI, -6.15 - 1.81) respectively. Other
differences that were not statistically significant were
fasting glucose, HbA1C, triglyceride concentration and
CRP. There appeared to be no difference between
groups for fasting insulin, cholesterol, LDL cholesterol
and HDL cholesterol.Changes in weight
The median weight of the active and waitlisted groups
was plotted at each assessment time point (Figure 2).
Only participants weight measurements for all three
time points were included. Participants lost to follow-up
were on average heavier in the active group and lighter
in the waitlisted group.
Figure 2 Median weight for the active and waitlisted
participants with complete data from T1 to T3.
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This study is a pragmatic randomised controlled trial of
a 12-week physical activity and nutrition program with
structured group exercise classes for Aboriginal and
Torres Strait Islander women. Only limited research
reports the results of interventions with a robust con-
trolled design with measured endpoints, including
follow-up 3 months after cessation of the intervention.
Despite relatively low attendance rates for the program,
we found a modest but significant weight loss in the
active group compared to the control group, and
favourable changes in blood pressure and other meta-
bolic measures. The small number of participants in this
trial might well explain the lack of statistically significant
results in some of these outcome measures.
Research consistently shows a strong association be-
tween weight loss and reduction in blood pressure [6,7].
A meta-analysis of 25 trials found for each kilo of weight
lost through energy restriction, increased physical activ-
ity or both, systolic blood pressure reduced by
1.05 mmHg (95% CI, 1.43 - 0.66) and diastolic blood
pressure by 0.92 mmHg (95% CI, 1.28 - 0.55) [7].
Exercise interventions for weight loss have had mixed
results. Most studies have reported modest weight loss
(1–3 kg) even though the studies tended to be more in-
tensive, with higher compliance and longer trial periods
than this study [5,19]. A meta-analysis of 43 randomised
control trials using exercise as the primary means
for weight loss found that exercise combined with
diet resulted in a weight loss of 1.1 kg, and that increas-
ing the intensity of the exercise program increased
weight loss (1.5 kg). Interventions including only an ex-
ercise component resulted in less weight loss [5]. Our
study is the first to report the results of a group inter-
vention study including twelve weeks of structured phys-
ical activity and nutrition education sessions for
Aboriginal and Torres Strait Islander women living in an
urban setting.A 10-week community exercise and nutrition program
(CHAPP) targeting obese African American adults found
a smaller effect on body mass at the three month follow-
up, with a loss of 1.3 kg. The effect on diastolic blood
pressure was similar, -2.8 mmHg, but they achieved a
greater change in systolic pressure -5.8 mmHg [13].
Compared to a 4-month program targeting obese Maori
men and women in New Zealand our weight loss was
less, 2.5 kg compared to 3.1 kg (95% CI, -4.0 - -2.1) [12].
The study of Maori men and women also found a larger
improvement in systolic blood pressure, reduced by
7 mmHg (95% CI, 13–1) but less of an improvement
in diastolic blood pressure, reduced by 1 mmHg (95% CI,
-4 - -2) [12]. The 8-week pilot study, the Thursday Island
Women’s Fitness Challenge, did not find any weight loss
and blood pressure was not assessed. However they did
find a reduction in waist circumference, of 4.93 cm,
which was not replicated in our trial [14]. These studies
had a small number of participants (n = 70, 30, and 10
respectively) and are pre-post designs with no control
group. Thus, there is the potential for selection bias in
these study findings [12].
This study has limitations, most significantly the large
amount of missing data. The project implemented many
actions to improve data collection. Different modes of
collection were offered, including home or office visits,
to conduct anthropometric assessments and collect fast-
ing blood samples. However, appointments were still dif-
ficult to organise and were often cancelled or
rescheduled. Only one-half of participants attended their
T3 anthropometric assessment and slightly less com-
pleted their pathology test. This significantly reduced the
sample size.
Program ‘dose’ was another issue. Attendance at the
exercise classes and nutrition workshops was low.
Participants in the active group attended on average 40%
of the recommended group exercise sessions. This
situation is likely to have reduced the effectiveness of
the program. Thus, the findings presented here are a
conservative picture of the potential effectiveness of
this intervention. To gain insight into the factors influ-
encing participation, a qualitative analysis of post-
program interviews is being undertaken and a paper will
be forthcoming.
The project also experienced difficulties in the assess-
ment of waist circumference and blood pressure. The
ISAK accredited assessors’ accuracy with assessing waist
circumference in this difficult-to-measure group is un-
known. The assessors were conscious to be sensitive and
appropriate with the participants and in some cases it
was not appropriate to palpate for landmarks. The asses-
sors also had some difficulties ensuring the tape measure
was exactly horizontal. Additionally, some participants
chose not to remove items of clothes from around their
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formed over their clothing. The large arm cuff for the
Ormon blood pressure machine was ill-fitting on upper
arms of different shapes and consequently gave some
error readings which resulted in some missing data for
some of the participants with high BMIs.
Conclusions
The Aboriginal and Torres Strait Islander Women’s Fit-
ness Program found modest reductions in weight, BMI
and blood pressure, which were evident at the immedi-
ate post program assessment with further improvement
at the three month follow-up assessment. Changes in
the primary outcome measure, waist circumference, and
metabolic measures were not evident. Longer term
follow-up of all participants would be valuable, as similar
programs undertaken in other populations show mixed
results, especially over the longer term.
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